Welcome to Our Skin, a Personal Discovery Podcast. Each week, host Holly Frey showcases a personal story from someone who lives–and thrives!--while managing psoriasis. Being diagnosed with a chronic skin condition can throw anyone off track, but Our Skin guests have a message of hope: a diagnosis can be an opportunity to discover new things about ourselves, our grit, and our power. In addition to these tales of hope, Frey and her guests plunge into the jaw-dropping, bizarre, and occasionally ...
…
continue reading
MP3•Episode home
Manage episode 245009765 series 1052357
Content provided by Cover2 Resources and Cover 2 Resources. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cover2 Resources and Cover 2 Resources or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
On October 21st, just as a landmark opioid trial was about to begin, a $260 million settlement was reached. The deal negotiated between three major opioid distributors, one opioid manufacturer, and Cuyahoga and Summit Country Ohio, resulted in a combination of cash payouts, and donations of addiction treatments. The first of its kind, this case could become a settlement model for thousands of similar cases against the pharmaceutical industry. The details of the settlement are extremely dense. To help break them down, Andrew Pollis, Case Western Reserve professor of Law and friend of the podcast, is joining us to share his reaction to this week’s settlement news. Finally, we conclude today’s podcast by revisiting our op-ed collaboration about honoring the lives lost in the opioid epidemic with a settlement providing the best chance at long-term recovery for those in need. Join us on today’s podcast, as Andrew Pollis returns to share his insight into one of the opioid epidemics' most influential cases.
…
continue reading
284 episodes